跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXICODONA/NALOXONA SANDOZ 30 MG/15 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OXICODONA/NALOXONA SANDOZ 30 MG/15 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Approved
STANDARD
OXICODONA/NALOXONA SANDOZ 30 MG/15 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 1, 2021
Approval ID
21a20f98ba4461de
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
21a20f98ba4461de
Drug Cima Aemps Name
OXICODONA/NALOXONA SANDOZ 30 MG/15 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Register Number
86060
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2021-07-01
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
30/15 mg/mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Estupefacientes
Commercialized
Yes
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
OXICODONA HIDROCLORURO
30 mg
NALOXONA HIDROCLORURO
15 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 1, 2021
Approval ID
21a20f98ba4461de
Type
Standard
Back to CIMA-AEMPS Approvals